Head-to-Head

Absci Corporation Common Stock vs. Medpace Holdings, Inc. Common Stock

ABSI

Absci Corporation Common Stock

$9.65 +4.10%

VS MEDP

Medpace Holdings, Inc. Common Stock

$624.21 +1.94%

Absci Corporation Common Stock and Medpace Holdings, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

ABSIMEDP
Market Cap $1.66 billion $17.09 billion
Revenue (TTM) $2.78 billion
Net Income (TTM) $491.50 million

MEDP leads on 1 of 1 size & scale factors.

Valuation

ABSIMEDP
P/E Ratio 36.65
Price / Book 39.39
Price / Sales 6.14

ABSI and MEDP split the valuation factors evenly.

Profitability

ABSIMEDP
Net Margin 17.67%
Return on Equity 113.29%

ABSI and MEDP split the profitability factors evenly.

Risk & Sentiment

ABSIMEDP
Short Interest 0.12% 1.35%

ABSI leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABSI overview, ABSI financials, MEDP overview, MEDP financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.